                         SEQUENCE LISTING

<110>  Grobe, Justin  L.
       Santillan, Mark K.
 
<120>  THERAPEUTIC STRATEGIES FOR THE TREATMENT OF PREECLAMPSIA

<130>  139766.00018

<150>  US 61/762,830
<151>  2013-02-08

<150>  US 61/906,074
<151>  2013-11-13

<150>  US 61/762,831
<151>  2013-02-08

<160>  30    

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NKCC2 FORWARD

<400>  1
ccatggtaac ctctatcact gggt                                              24


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NKCC2 reverse

<400>  2
tcaagcctat tgacccaccg aact                                              24


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NCC FORWARD

<400>  3
aagtcgggtg gcacctattt cctt                                              24


<210>  4
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NCC reverse

<400>  4
ttacggtttc tgcaaagccc acag                                              24


<210>  5
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NHE3 FORWARD

<400>  5
tcctctcagc cattgaggac atct                                              24


<210>  6
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NHE3 REVERSE

<400>  6
actttgctga ggaacttccg gtca                                              24


<210>  7
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC -1 forward

<400>  7
acaatggttt gtccctgaca ctgc                                              24


<210>  8
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC -1 REVERSE

<400>  8
tcacgttgaa gccaccatca tcca                                              24


<210>  9
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC-2 FORWARD

<400>  9
tctgccaacc ctgggactga attt                                              24


<210>  10
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC-2 REVERSE

<400>  10
tggcatagat gccctcctct ctaa                                              24


<210>  11
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC-3 FORWARD

<400>  11
gccaatcagt gtgcaagcaa tcct                                              24


<210>  12
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays ENaC-3 REVERSE

<400>  12
ttatttgctg gctttggtcc cagg                                              24


<210>  13
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NKA-1 forward

<400>  13
tgaagctgac accacggaga atca                                              24


<210>  14
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays NKA-1 REVERSE

<400>  14
tgccgcttaa gaataggcag gtt                                               23


<210>  15
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays V2R FORWARD

<400>  15
tgtgattgtc tacgtgctgt gctg                                              24


<210>  16
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays V2R REVERSE

<400>  16
gggttggtac agctgttaag gcta                                              24


<210>  17
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP1 FORWARD

<400>  17
ctgggcattg agatcattgg cact                                              24


<210>  18
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP1 REVERSE

<400>  18
tgataccgca gccagtgtag tcaa                                              24


<210>  19
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP2 FORWARD

<400>  19
tagccctgct ctctccattg gttt                                              24


<210>  20
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP2 REVERSE

<400>  20
aaacttgcca gtgacaactg ctgg                                              24


<210>  21
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP3 FORWARD

<400>  21
atggtggctt cctcaccatc aact                                              24


<210>  22
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP3 REVERSE

<400>  22
aggaagcaca ttgcgaaggt caca                                              24


<210>  23
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP4 FORWARD

<400>  23
tgccagctgt gattccaaac gaac                                              24


<210>  24
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays AQP4 REVERSE

<400>  24
tcccatgata actgcgggtc caaa                                              24


<210>  25
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays PGES FORWARD

<400>  25
tttgcaacaa gtactggccc atgc                                              24


<210>  26
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays PGES REVERSE

<400>  26
tgttcggtac acgttgggag agat                                              24


<210>  27
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays UT1-A FORWARD

<400>  27
cactggcgac atgaaggaat gcaa                                              24


<210>  28
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SYBR188 green assays UT1-A REVERSE

<400>  28
gggttgttga caaacatcac ctgagc                                            26


<210>  29
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  B-actin Forward

<400>  29
catcctcttc ctccctggag aaga                                              24


<210>  30
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  B-actin Reverse

<400>  30
acaggattcc atacccaaga aggaagg                                           27


